Anti-trypanosomatid drug discovery: an ongoing challenge and a continuing need

Nature Reviews Microbiology 15, 217 (2017).
doi:10.1038/nrmicro.2016.193

Authors: Mark C. Field, David Horn, Alan H. Fairlamb, Michael A. J. Ferguson, David W. Gray, Kevin D. Read, Manu De Rycker, Leah S. Torrie, Paul G. Wyatt, Susan Wyllie & Ian H. Gilbert
The WHO recognizes human African trypanosomiasis, Chagas disease and the leishmaniases as neglected tropical diseases. These diseases are caused by parasitic trypanosomatids and range in severity from mild and self-curing to near invariably fatal. Public health advances have substantially decreased the effect of these diseases

Source: Nature Reviews Microbiology - February 26, 2017 Category: Microbiology Authors: Mark C. Field David Horn Alan H. Fairlamb Michael A. J. Ferguson David W. Gray Kevin D. Read Manu De Rycker Leah S. Torrie Paul G. Wyatt Susan Wyllie Ian H. Gilbert Tags: Review Source Type: research